Skip to main content
. 2022 Dec 8;10:tkac047. doi: 10.1093/burnst/tkac047

Table 5.

Comparison between topical agents and TransCyte™ skin substitute according to Demling and DeSanti’s study [47]

Mean ± S.D. Face care (h/day) Pain scale Healing time (days)
During Between
Major burns
 Topical agents 1.9 ± 0.5 5 ± 1 4 ± 2 14 ± 4
 TransCyte™ skin substitute 0.35 ± 11a 2 ± 1a 2 ± 0.1a 8 ± 2a
Minor burns
 Topical agents 2.2 ± 0.4 5 ± 1 3 ± 2 12 ± 3
 TransCyte™ skin substitute 0.4 ± 0.01a 2 ± 1a 1 ± 0.5a 8 ± 1

aSignificantly diffferent from topical agent, p < 0.05